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Abstract
Human endogenous retroviruses (HERVs) are globally silent in somatic cells. However, some HERVs
display high transcription in physiological conditions. In particular, ERVWE1, ERVFRDE1 and ERV3,
three proviruses of distinct families, are highly transcribed in placenta and produce envelope proteins
associated with placenta development. As silencing of repeated elements is thought to occur mainly by
DNA methylation, we compared the methylation of ERVWE1 and related HERVs to appreciate whether
HERV methylation relies upon the family, the integration site, the tissue, the long terminal repeat (LTR)
function or the associated gene function. CpG methylation of HERV-W LTRs in placenta-associated
tissues was heterogeneous but a joint epigenetic control was found for ERVWE1 50LTR and its juxtaposed
enhancer, a mammalian apparent LTR retrotransposon. Additionally, ERVWE1, ERVFRDE1 and ERV3 50LTRs
were all essentially hypomethylated in cytotrophoblasts during pregnancy, but showed distinct and stage-
dependent methylation proﬁles. In non-cytotrophoblastic cells, they also exhibited different methylation
proﬁles, compatible with their respective transcriptional activities. Comparative analyses of transcrip-
tional activity and LTR methylation in cell lines further sustained a role for methylation in the control
of functional LTRs. These results suggest that HERV methylation might not be family related but copy-
speciﬁc, and related to the LTR function and the tissue. In particular, ERVWE1 and ERV3 could be
developmentally epigenetically regulated HERVs.
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1. Introduction
Human endogenous retroviruses (HERVs) are
constitutive elements of the human genome.
1 Now
transmitted exclusively in a Mendelian way, they
derived through infectious retrovirus integration in
the germ-line DNA and transmission to the offspring,
millions of years ago. Different waves of retroviral
endogenization and expansion by retrotranspositional
events (copying mechanism) led to the formation of
at least 31 phylogenic multicopy families of HERVs,
corresponding to over 400 000 HERV copies, dis-
persed throughout the genome.
2 Because of the
accumulation of mutations, the contemporary HERV
families consist of collections of heterogeneous HERV
elements, ranging from full-length proviruses [gag,
pol and env gene sequences ﬂanked at each extremity
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DNA RESEARCH 16, 195–211, (2009) doi:10.1093/dnares/dsp011by a long terminal repeat (LTR)] to isolated LTRs
derived from inter-LTR recombination events.
Some families or family members of HERVs are natu-
rally expressed in particular physiological contexts and
displayphysiologicalfunctions.Thisisnotonly thecase
in several LTRs active as alternative promoters of cellu-
lar genes in placenta
3,4 but also in proviruses driving
the expression of their own retroviral protein, e.g.
ERVWE1, ERVFRDE1 and ERV3, three phylogenically
unrelated proviruses highly active in the placenta.
ERVWE1 belongs to the HERV-W family and contains
gag and pol pseudogenes but its envelope gene ORF
has been preserved (for review see Gimenez and
Mallet
5). This domesticated envelope, dubbed
Syncytin-1, was demonstrated to be involved in tro-
phoblast fusion occurring during placental develop-
ment
6 and was also recently proposed to exert
anti-apoptotic function
7 and to induce proliferation.
8
The ERVFRDE1 provirus from the HERV-FRD family
9
and the ERV3/envR provirus from the ERV3/HERV-R
family
10 also code for functional envelope proteins
that probably play a role in placental development,
i.e. Syncytin-2 and ERV3 Env, respectively.
9,11,12
Syncytin-2, which is fusogenic
9 and immunosuppres-
sive,
13 appears strictly expressed in placenta.
11,14 In
contrast, ERV3 Env, which inhibits cell proliferation
15
and exhibits immunosuppressive properties,
13 is tran-
scribed at various levels in almost all investigated
tissues.
11,16,17 Except for these few examples of loca-
lized physiological activities, HERV elements appear
essentially silent in somatic cells.
HERV silencing is thought to be the result of the
methylation of the LTRs (50 LTR, 3 0 LTR or solo LTR),
which,asforinfectiousretroviruses,containtheregulat-
ory elements and, in particular, the retroviral promoter
in the LTR U3-subregion. This epigenetic process,
which occurs in mammals on cytosines of 50CpG dinu-
cleotides, hasthe property toblock the regulatory func-
tion of the targeted sequence.
18,19 It is believed to have
evolved primarily as a defense mechanism against the
possible deleterious effects of retroelements and
repeated sequences.
20 Indeed, whole genome methyl-
ation studies showed that repeated elements, including
HERVs, are globally methylated in normal somatic
cells.
21–23 Methylation-mediated repression of HERV
LTRs activity was illustrated in vitro by methylation
assays on functional HERV-K 50LTRs.
24 Conversely,
demethylation-mediated derepression of copies from
theHERV-K(HML-2)andHERV-Efamilieswasillustrated
in cell culture by the use of the demethylating agent 50-
aza-deoxycytidine.
25,26 In vivo HERV transcripts have
been detected in numerous pathological situations
and predominantly in autoimmune/inﬂammatory dis-
eases
26–30 and tumoral contexts.
31–34 Methylation
deregulations are strongly associated with tumors,
22,23
and interestingly, tumoral transcriptional reactivations
of HERVs have been associated with LTRs hypomethyla-
tion for some contexts when compared with normal
tissues. This is the case of one HERV-H copy in gastroin-
testinal cancers,
35 several HERV- K members in urothe-
lial carcinomas
36 and human primary testicular
tumors
25 and the HERV-W family in ovarian
carcinomas.
37
Thus,theimpactofDNAmethylationinthecontrolof
HERV elements seems obvious. However, HERV methyl-
ation status in physiological conditions has been less
considered. HERV-E LTRs acting asalternative promoters
ofcellulargenesinplacentawereshowntobeunmethy-
latedinthistissue,buthypermethylatedinbloodwhere
they do not exert promoter function.
38 Likewise, the
expression of the domesticated ERVWE1 locus has
been correlated with hypomethylation of its 50LTR in
placenta in comparison with other tissues.
39 Thus,
HERV activity in physiological context seems related to
a lack of methylation. The HERV-W family contains
 80 full-length proviruses with ﬂanking LTRs, 200 ret-
rosequences with incomplete LTRs and 400 solitary
LTRs.
40,41 However, in contrast to ovarian carcinoma,
expression of HERV-W family in placenta mainly results
from the activity of the ERVWE1 locus.
42 The high and
speciﬁcplacentalexpressionofERVWE1hasbeenattrib-
uted to the co-optation of its own retroviral promoter,
localized in the 50 LTR, with an LTR retrotransposon of
MaLR (mammalian apparent LTR retrotransposon)
type, acting as a trophoblast-speciﬁc enhancer
(TSE).
43–46 Still neither the methylation status of this
enhancer LTR nor the methylation status of family
related LTRs is known. Similarly, the methylation status
of other proviruses producing envelope proteins, like
ERVFRDE1 and ERV3, are unknown.
Generally, the features determining HERV methyl-
ation status are unknown. In addition, it remains
poorly understood whether methylation not only
can repress but also regulate HERV activity. Here, we
asked whether ERVWE1 50LTR methylation is related
to the HERV family, the LTR role, the LTR-surrounding
genomic context, the tissue or the implication of its
envelope gene in a physiological process. For this
purpose, we investigated and compared the methyl-
ation proﬁles of ERVWE1 50LTR with ERVWE1 MaLR
LTR enhancer, different HERV-W LTRs and the 50LTRs
from HERVs probably involved in placenta develop-
ment and maintenance. Whether transcriptional
activity and methylation were correlated was further
addressed using model cell lines.
2. Materials and methods
2.1. Biological samples
Placental tissues from the ﬁrst trimester legally
induced abortions (8–12 weeks of gestation) were
196 ERVWE1/Syncytin-1 and Other HERV LTR Methylation [Vol. 16,obtained from the Department of Obstetrics and
Gynecology at the Broussais, Saint Vincent de Paul
and Cochin Hospitals. Second trimester placental
tissues were collected at the time of termination of
pregnancy at 15 and 25 weeks of gestation (in
weeks of amenorrhea) in trisomy 21-affected preg-
nancies. Fetal Down syndrome was diagnosed by kar-
yotyping of amniotic ﬂuid cells. The indication of
amniocentesis was the maternal age. Term placentas
were obtained after elective cesarean section from
healthy mothers near term with uncomplicated preg-
nancies. With written informed consent of the preg-
nant woman, the following samples were collected
at term: a fragment of the placenta, umbilical cord
fetal blood and maternal blood. The placenta biopsy
sample was collected at a depth of 1 cm and at a dis-
tance of 8 cm from the edge of the placenta, with the
maternal side facing upward. The use of these biologi-
cal samples was approved by local ethical committee.
Villous cytotrophoblastic cells were isolated by
sequential enzymatic digestion of chorionic villi from
the ﬁrst trimester, second trimester and term pla-
centa and puriﬁed on a discontinuous percoll gradi-
ent, as described previously.
47–49 These cells were
positively stained for cytokeratin 7 at 95%, indicating
the cytotrophoblastic origin of the cells. Placental
ﬁbroblasts were isolated by prolonged enzymatic
digestion from ﬁrst trimester chorionic villi as in
Malassine et al.
50 Fibroblastic cells (1.25  
10
5 cells/mL) were plated on 35-mm plastic dishes
(TPP, Switzerland) and cultured for 48 h, and the
culture medium was changed daily. These cultured
ﬁbroblasts were characterized using immunocyto-
chemistry. It was found that 98% of the cells were
vimentin positive and also positive for a monoclonal
antibody against speciﬁc ﬁbroblast antigen (clone
ASO2, Dianova, Hamburg, Germany). Owing to the
limited amount of cells, only DNA was extracted.
2.2. Cell lines
Human choriocarcinoma cells BeWo b30 were
cultured in F-12K medium (Invitrogen, Carlsbad, CA,
USA) supplemented with 10% fetal calf serum (FCS)
(Invitrogen). Human ovarian carcinoma cells OVCAR-3
wereculturedintheRPMI1460mediumsupplemented
with 20% FCS (LGC Promochem, Molsheim, France).
Human astrocytoma cells 85HG66 were cultured in
the DMEM medium (Invitrogen) supplemented with
10% FCS (Invitrogen).Monocytoid cells U937 were cul-
tured in the RPMI 1640 medium containing 10% FCS.
All media were supplemented with antibiotics, i.e.
100 IU of penicillin/mL, 100 mg of streptomycin/mL
and 0.25 mg/mL amphotericin B (Fungizone)
(Invitrogen).Cellswere maintained inculture untilcon-
ﬂuence before DNA and RNA extractions.
2.3. Sodium bisulﬁte modiﬁcation of genomic DNA
Genomic DNA from conﬂuent cell lines, blood
samples and villous placenta section was isolated
using the NucleospinwBlood or Tissue kit following
the manufacturer’s instructions (Macherey-Nagel).
Genomic DNA from cytotrophoblasts and placental
ﬁbroblasts was obtained following the overnight pro-
teinase K lysis and phenol extraction procedure.
51 To
perform methylation studies, genomic DNA was sub-
mitted to sodium bisulﬁte treatment. This procedure
converts all methyl-free cytosines into uracils,
whereas methylated cytosines remain unchanged.
For each sample, 1 mg of genomic DNA was mixed
with 3 mg of carrier pUC18 DNA in a ﬁnal volume of
100 mL. The mixture was heated for 10 min at 658C,
and the DNA denatured in 20 mL NaOH 3N for
30 min at 378C. To convert unmethylated cytosines,
denatured DNA was incubated in 50 mL hydroquinone
0.1M and 350 mL sodium bisulﬁte 3M for 16 h at
508C. Modiﬁed DNA was then puriﬁed using Wizard
DNA Clean-up System (Promega) and eluted in
50 mL of sterile water. DNA modiﬁcation was com-
pleted by incubation in 5 mL NaOH 3N for 15 min
at room temperature. DNA was washed by precipi-
tation for 30 min at 2208Ci n1 0mL of ammonium
acetate 5M and 200 mL of absolute ethanol, followed
by centrifugation at 13 000 rpm at 48C for 10 min.
An additional wash was realized by centrifugation in
500 mL ethanol 70% for 5 min. The DNA pellet was
eluted in 30 mL of sterile water.
2.4. DNA methylation analyses
Strand-speciﬁc primers were designed to speciﬁcally
amplify the HERV LTR copy of interest on bisulﬁte
modiﬁed DNA by nested PCR (Table 1). First-round
PCR was accomplished in a 50 mL mixture containing
3 mL of modiﬁed DNA, 0.66 mM of each primer, 1 mM
of each dNTP, 1 U of DyNAzyme polymerase
(Fynnzyme), 1  Mg-free DyNAzyme buffer
(Fynnzyme) and 1.5 mM MgCl2 (Fynnzyme). PCR
cycling conditions were: 5 min at 948C; 35 cycles as
follows: 1 min at 948C, 2 min at a temperature
depending on the primer set (Table 1), 1 min at
728C; and a ﬁnal extension at 728C for 5 min.
Nested PCR was performed on 1 mL of the ﬁrst PCR
products with internal primers in the same reaction
mixture conditions. Nested PCR cycling conditions
were 5 min at 948C; 30 cycles as follows: 1 min at
948C, 1 min at a temperature depending on a
primer set (Table 1), 1 min at 728C; and a ﬁnal exten-
sion at 728C for 5 min. PCR fragments were gel-
extracted, cloned and sequenced using plasmid
forward and reverse primers. To determine CpG
methylation, and cytosine conversion rate, the
sequence of each clone was aligned and compared
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all cytosines converted into thymines independently
of their context). CpG positions were located and
the methylation status at each CpG site observed. To
prevent false-positive interpretation, only sequences
with more than 95% of converted bases (all cytosines
out of CpG context) were taken in analyses.
Independence of the sequences was determined
based either on their within-sample unique methyl-
ation pattern and/or on unique non-conversion of
cytosines out of CpG context. For some samples, con-
version rate was too high to determine the molecular
independence of sequences based on unconverted
cytosines. In these cases, more than 10 sequences
were systematically analyzed to ensure methylation
pattern representativity, and results were conﬁrmed
on other samples.
2.5. Real-time qRT–PCR
HERV LTR-derived transcript-speciﬁc primer
sequences were determined using Oligo 6 software
(MBI, Cascade, USA) or taken from published work
(Table 2). Systems speciﬁcity was checked by in silico
PCR on the human genome (UCSC Genome Browser:
http://genome.ucsc.edu/cgi-bin/hgPcr; reference
assembly: March 2006).
Total RNA was isolated using the RNeasy Midi Kit
including an on-column DNAse treatment in accord-
ance with the manufacturer’s instructions (Qiagen,
Hilden, Germany). RNA quantity was measured at
OD260 in a spectrophotometer, and RNA quality was
assessed with a Bioanalyzer capillary electrophoresis
device (Agilent, Palo Alto, USA). For each sample,
5 mg of total RNA was converted into cDNA in a ﬁnal
volume of 20 mL with random hexamer primers
using ThermoScript RT–PCR System for ﬁrst-strand
cDNA synthesis (Invitrogen) following the manufac-
turer’s recommendations. Reverse-transcriptase-free
reactions were carried out simultaneously to verify
the absence of contaminating genomic DNA.
Real-time PCRs were performed with the Stratagene
Mx3005P quantitative PCR system (Stratagene, La
Jolla, CA, USA) using the SYBR (with dissociation
curve) option. Each quantitative PCR was performed
on 10 mL of 100-fold diluted cDNA, in a PCR mix
containing 0.2 mM of individual target primers,
10 mLo f2   Brilliant SYBR Green QPCR Master Mix
(Stratagene) and water to reach a volume of 25 mL.
Housekeeping genes were analyzed in the same
experiment as the target transcripts. The experiments
were performed in duplicate and included RT-minus
controls. Following a 10 min denaturation at 958C,
gene ampliﬁcation was performed as follows:
Table 1. Primer sets used for determination of HERV LTRs methylation
Sequence ampliﬁed Primer sequence for HERV LTRs methylation analyzes
a Length (bp) Hyb. temp. (8C)
MaLR[LTR]–ERVWE1[50LTR] PCR1 U1 50(-208)-AATTCATTCAACATCCATTC 1036 45
L1 50(þ828)-GGTttAATATTAtTtAttAtTTTGGA
Nested PCR U2 50(-177)-CTCTtaCCTTCCTATACTCTCTaaA 507 51
L2 50(þ330)-AGAGTGtAGTTGtAAGATTTAATAGAGT
ERVWE1[env-30LTR] PCR1 U1 50(-232)-aCTaTAAAACTACAAATaaAaCCCA 984 50.9
L1 50(þ752)-TGtAtttTtATGGTTGTGTTAtTT
Nested PCR U2 50(-222)-TACAAATaaAaCCCAAaATaCA 553 59.3
L2 50(þ331)-AGAGTGtAGTTGtAAGATTTAATAGAGT
HW_4[50 LTR] PCR1 U1 50(-128)-CCAACATCACTAACACAACC 550 55
L1 50(þ422)-GGGAGTtAGtAAGGGGTtTG
Nested PCR U2 50(-113)-CAACCTaTTAaACAAAaCTaAATT 428 43.9
L2 50(þ315)-AGATTTAATAGAGTGAAAAtAGAGtTt
HW_12[solo LTR] PCR1 U1 50(-13)-aCCCACATCCAATTaAaAa 810 45
L1 50(þ799)-GATGAATGTGTTAtAGGGGTt
Nested PCR U2 50(þ3)-AaAaACAaaACTAaCTaaATTTCC 313 46.2
L2 50(þ315)-AGATTTAATAGAGTGAAAAtAGAGtTt
ERVFRDE1[50 LTR] PCR1 U1 50(-36)-CAaTTCTATCAaaAaaCCATT 677 54.7
L1 50(þ641)-GGGGTAGGTTAGTAAGtAGGA
Nested PCR U2 50(-20)-CCATTAaaTTAAaCTaaTTCTaTTAa 568 50.9
L2 50(þ548)-GTtTTAttAtTAGGGAAGGTAGA
ERV3[50 LTR] PCR1 U1 50(-25)-GTTATAtTttTATAGGtAGTGTATATG 764 53.8
L1 50(þ739)-aaTCATaaaAaAaCCAATCTCC
Nested PCR U2 50(-19)-tTttTAtAGGtAGTGTATATGAGGt 644 57.8
L2 50(þ625)-TaTAaTCTCCCCTCCTaaCT
aNucleotides in bold and lowercase letters represent changes in primers relative to the genomic sequence due to bisulﬁte
treatment, as follows: t is C and a is G in the untreated sequence. The position relative to the LTR start is given in
parentheses.
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for 30 s. Melting curve acquisition was performed
within a 55–958C range, and resulting amplicons
were sequenced and analyzed to check for false-
positive detection. 18S and HPRT were the most
stable housekeeping genes among the samples (vari-
ation less than a factor of 4.05 and 4.25, respectively).
The geometric mean of their expression average was
calculated and used to normalize for differences in
the amount of total RNA added to the reaction. The
relative quantiﬁcation of transcripts was then calcu-
lated with respect to an external standard calibration
curve established using serial dilutions of puriﬁed
genomic DNA ampliﬁcation products. The copy
number of LTR-derived transcripts was related to
1000 cells, corresponding to  12.5 ng of total RNA.
2.6. In vitro methylation of ERVWE1 promoter
constructs and luciferase assays
To investigate the inﬂuence of methylation on the
different regulatory regions of the ERVWE1 promoter
activity, we used the previously described reporter
plasmid pGL3-basic ﬁreﬂy luciferase HW-67/310
(TSE-U3), HW-1/310 (U3 full-length) and HW-90/
310 (minimal promoter) constructs.
43 Three micro-
grams of each pGL3-LTR vectors were methylated in
a reaction mix containing 4 U of SssI CpG methylase,
1  NEBuffer 2 and 160 mM S-adenosyl-methionine
(SAM) in a ﬁnal volume of 20 mL (New England
Biolabs). The methylation reactions were realized at
378C and stopped after 30, 60, 120 and 240 min
by heat inactivation of SssI at 658C for 20 min. The
negative control (no methylation) underwent
the same treatment lacking SAM. To determine the
methylation level of each reaction, 500 ng aliquots
were digested with 0.5 U BstUI methylation-sensitive
endonuclease (New England Biolabs) in 1  NEBuffer
for 1 h at 608C, and restriction proﬁles were analyzed
after electrophoresis on a 1% agarose gel. BeWo b30
choriocarcinoma cells at 60–70% conﬂuence were
seeded in 12-well plates. Twenty-four hours later,
cells were co-transfected with 0.7 mg of pGL3-LTR
ﬁreﬂy luciferase plasmid either methylated or not
(-SAM) and 35 ng of pRL-TK Renilla luciferase
plasmid for internal standardization (Kit Dual-
Luciferasew Reporter Assay System, Promega) by use
of Lipofectamine Plus (GibcoBRL-Life Technologies,
Invitrogen) as recommended by the manufacturer.
Cells were lysed 24 h after transfection with passive
lysis buffer (Promega). Fireﬂy and Renilla luciferase
activities were measured by using the Dual-
Luciferasew Reporter Assay 1000 System (Promega)
according to the manufacturer’s instructions.
Promoter activities were normalized to the internal
Renilla luciferase control, i.e. (Fireﬂy luciferase
activity/Renilla luciferase activity)   100. All reporter
gene assays were performed in triplicate.
3. Results and discussion
3.1. Methylation of HERV-W LTRs in placenta
and placenta-associated tissues
3.1.1. Description of the investigated HERV-W
LTRs ERVWE1/Syncytin-1 (Ch7q21.2;
AC007566) transcription is regulated by two distinct
elements, i.e. the ERVWE1 50LTR U3 promoter region
and an adjacent upstream TSE. This enhancer is
located within a MaLR solo LTR within which the
Table 2. Primer sets used for analyses of HERV LTR-derived transcriptional activity
Region ampliﬁed Primer sequence for real-time qRT–PCR (50-30) Length (bp) Hyb. temp. (8C)
ERVWE1-env
a f CCCCATCGTATAGGAGTCTT 207 55
r CCCCATCAGACATACCAGTT
ERVWE1[30LTR]-U5 f GTCCATGTTTCTTACGGCTTG 402 55
r GTGTTACTTGGGGGTCCTTG
HW_4[50LTR]-U5 f GGTTCGTGCTAATTGAGCTG 167 55
r ATGGTGGCAAGCTTCTTGTT
HW_12[solo LTR]-U5 f CCATTGCTCCTGCACAGTTA 99 55
r TTAGAAGCAGTGGGTCATGGA
ERVFRDE1-env
a f GCCTGCAAATAGTCTTCTTT 114 55
r ATAGGGGCTATTCCCATTAG
ERV3-env
a f CCATGGGAAGCAAGGGAACT 141 55
r CTTTCCCCAGCGAGCAATAC
18S f TTCGGAACTGAGGCCATGAT 101 55
r TTTCGCTCTGGTCCGTCTTG
HPRT f GTGATGATGAACCAGGTTATGACCTTG 261 55
r CTACAGTCATAGGAATGGATCTATCAC
aFrom De Parseval et al.
11
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ago.
43,46 We chose to analyze together the methyl-
ation status of these two co-opted but unrelated
LTRs involved in Syncytin-1 regulation, further
referred to as MaLR[LTR]–ERVWE1[50LTR]. As a
minimal model to test the family related methylation
process hypothesis, three other HERV-W LTRs were
studied: ERVWE1[30LTR], HW_4[50LTR] and
HW_12[solo LTR]. ERVWE1[30LTR] is the 30LTR of
ERVWE1 provirus and represents topographically and
phylogenetically the closest HERV-W LTR relative to
ERVWE1[50LTR]. HW_4[50LTR] is an another functional
(data not shown) 50LTR belonging to a HERV-W
provirus located on chromosome 4 (Ch4p13;
AC024 022). HW_12[solo LTR] is a full-length solitary
HERV-W LTR localized on chromosome 12
(Chr12q24.32; AC005868), and a cDNA overlapping
the 51 bp at the 30 end of the U5 region was found to
have 100% identity with this part of the U5 region
(BC038735). These HERV-W LTRs exhibit common
but also speciﬁc CpG sites. An alignment of the inves-
tigated LTR U3 regions with highlighted CpG location
is presented in Fig. 1. About 200 bp of the upstream
env region from the ERVWE1[30LTR] and  100 bp of
the upstream region from the HW_4[50LTR], which
contains a MER110 type LTR, were co-ampliﬁed with
the respective HERV-W LTRs as controls of genomic
environment methylation.
3.1.2. Methylation unequally affects ERVWE1 50LTR
and other HERV-W LTRs The methylation
proﬁles of ERVWE1 and related HERV-W LTRs were
investigated in villous placenta and in non-tropho-
blastic cells composing the placenta, i.e. placental
ﬁbroblasts, fetal blood cells and maternal blood cells
(Fig. 2).
The phylogenetically related HERV-W LTRs schema-
tized in Fig. 2A were found highly methylated in a
majority of the investigated normal tissues (Fig. 2B–E).
In blood particularly, the high global methylation of
the HERV-W LTRs (from 85% to 98.2% of methylated
CpGs) was similar to the methylation range observed
for various LTRs of another HERV family, namely HERV-
E.
38 In placental ﬁbroblast, all LTRs were also highly
methylated (76.9–93.9% of methylated CpGs) except
for HW_12[solo LTR] whose methylation level was
found at its lowest (38.5%).
Thevillousplacentaappearedtobethetissuewiththe
lower level of methylation for all the LTRs except
HW_12[solo LTR]. In spite of it, both the methylation
levelsandthemethyl-groupdistributionwithinthemol-
ecules were different between the LTRs. Thus, CpG
Figure 1. Alignment of HERV-W LTR U3 promoter. ERVWE1[50LTR] and ERVWE1[30LTR] U3 region allelic forms were previously determined
on DNA ampliﬁed from 24 individuals (e.g. -132A. individual 132, allele A), i.e. 48 sequences.
45 HW_12[solo LTR] and HW_4[50LTR]
allelic forms derive from the annotated genome sequence (-A, reference allele; -B, alternative allele; SNP ID, rs6489086). Proportion
of each allelic form is given in hooks (e.g. [3], 3 of the 48 sequences hold this allelic form; [nd], not determined). CAAT box, TATA
box and transcription binding sites are indicated. Effective transcription factor binding sites are underlined; putative transcription
factor binding sites are marked by interrupted lines. CpG sites are indicated by gray background, their position in the U3 region is
given relative to ERVWE1 50LTR sequence.
200 ERVWE1/Syncytin-1 and Other HERV LTR Methylation [Vol. 16,methylation level was low for ERVWE1[50LTR] and
HW_4[50LTR] ( 40%), whereas it was relatively high
for ERVWE1[30LTR] ( 70%) and even higher for
HW_12[solo LTR] ( 80%). Methyl-group distribution
on ERVWE1[50LTR] was bimodal, as molecules were
either unmethylated (7 out of 12 clones) or densely
methylated. This feature, ﬁrst described by Matouskova
et al.,
39 appeared to be speciﬁc to ERVWE1 promoter.
The methylation defaults on the other HERV-W LTRs
were more diffusely distributed. Thus, some molecules
were found repeatedly unmethylated on deﬁnite CpG
sites, solely or together with contiguous CpGs (e.g. the
ﬁrst CpG of ERVWE1[30LTR] and the second CpG of
HW_4[50LTR]), but no molecule was found fully
unmethylated. On the contrary, some other CpG sites
were found constitutively methylated (e.g. the ﬁrst
CpG of HW_4[50LTR], the last CpG of ERVWE1[30LTR]
and the last two CpGs of HW_12[solo LTR]).
Interestingly in this tissue, the CpG site located at
the end of the ERVWE1[50LTR] ER binding site and
Figure 2. CpG methylation of HERV-W LTRs in placenta-associated tissues. (A) Schematic representation of MaLR[LTR]–ERVWE1[50LTR],
ERVWE1[env-30LTR], HW_4[50LTR] and HW_12[solo LTR] analyzed regions. LTR regions are represented by boxes and CpG
dinucleotides by circles on vertical bars. The U3 region (light gray) constitutes the retroviral promoter, transcription starts at the
U3/R boundary (arrow). For each LTR, CAAT and TATA boxes as well as putative and effective transcription factor binding sites
proximal to or containing CpG are indicated. Symbols above CpGs point out conserved CpGs between the different LTRs, asterisk
indicates CpGs conserved in all three LTRs. TSE, trophoblast-speciﬁc enhancer of ERVWE1 provirus, located in the 50part of the MaLR
LTR (white box at the 50 end); env, env-30UTR region of ERVWE1 provirus. The MER114 LTR located upstream from HW_4[50LTR] is
also represented (hatched box). (B–E) CpG methylation of (B) MaLR[LTR]–ERVWE1[50LTR], (C) ERVWE1[env-30LTR], (D) HW_4[50LTR]
and (E) HW_12[solo LTR]. Methylation was determined by bisulﬁte sequencing PCR in villous trophoblast of term placenta, related
fetal and maternal blood cells and in placental ﬁbroblasts from chorionic villi of a ﬁrst trimester placenta. Each sample result
originates from the same conversion reaction. Each line represents an independent clone as determined by methylation and/or
conversion differences. Methylated CpG are schematized by black circles, unmethylated CpGs by white circles, the mutated CpG
(SNP) in HW_12 is represented by a cross and CpGs with undetermined methylation state by gray circles. Global methylation
percentages in the U3 regions (highlighted in gray) as well as in the upstream regions (MaLR LTR, env, MER114 LTR) are given below
the respective area for each sample (in parentheses for non-U3 regions).
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methylated in approximately the same proportion of
clones in both LTRs (e.g. in 7 out of 10 clones and 9
out of 10 clones, respectively). Likewise, the CpG
located before the TATA box, conserved in
ERVWE1[30LTR] and HW_12[solo LTR], wasnot methyl-
ated in 4 out of 10 clones and 4 out of 12 clones.
However, other conserved CpGs did not have the same
pro-rata of methylation default (e.g. the CpG at the
U3/R border was not methylated in 2 out of 10 clones
of ERVWE1[30LTR] and 7 out of 10 of HW_4[50LTR] and
none of HW_12[solo LTR]), indicating that the ER
binding site and TATA-box-associated CpGs might
have particular methylation-targeting features.
These results demonstrate that LTRs from the same
phylogenetic lineage can be unequally methylated
within the same cellular type, suggesting that methyl-
ation establishment on HERV sequences might not be
family dependent.
3.1.3. Methylation of ERVWE1 LTRs and associated
MaLR LTR suggests a regional control By
deﬁnition, ERVWE1[50LTR] and ERVWE1[30LTR]
belong to the same proviral unit, but appeared differ-
entially methylated in villous placenta. This unmethy-
lation of the 50LTR corresponds with its promoter
function in placenta, as reported previously.
39 The
30LTR methylation in return may prevent a local com-
petition with ERVWE1 50LTR for promoter activity as
well as a 30LTR-derived transcriptional interference
with the nearby antisense-oriented ODAG/GATAD1
gene.
46 Such a differential methylation has been
observed for HTLV-1
52 and HIV-1 proviruses during
viral latency.
53 For these two retroviruses, however,
methylation favored repression of the 50LTR promoter
activity as the 50LTR was methylated and the 30LTR was
not. This suggests different methylation features for
exogenous/pathogenic and endogenous/domesti-
cated proviruses but possibly a conserved strategy to
prevent methylation spreading on both proviral LTRs,
like the use of boundary elements as hypothesized
for HTLV-1.
52 The CTCF protein is a factor able to
create boundaries between methylated and
unmethylated genomic domains.
54 Interestingly, two
domains containing potential binding sites for
CTCF were identiﬁed within ERVWE1 provirus
(www.essex.ac.uk/bs/molonc/spa.htm), respectively,
downstream from the 50 LTR and upstream from the
30 LTR region that we found methylated. Further inves-
tigations are required to ascertain CTCF functional rel-
evance in the context of proviruses. Nevertheless, it
appears that methylation might be regionally con-
trolled and linked either to the genomic environment
or to the LTR function.
The upstream ﬂanking sequence of three out of the
four HERV-W LTRs was ampliﬁed along with the
respective LTRs. Except for one clone in the villous pla-
centa tissue, the MaLR[LTR] directly upstream from
ERVWE1 presented the same methylation proﬁles as
the ERVWE1[50LTR], i.e. either unmethylated, partially
methylated or highly methylated (for methylation
values, see Fig. 2B). In contrast, the CpG sites con-
tained within the  200 bp of the env gene co-
ampliﬁed with ERVWE1[30LTR] appeared systemati-
cally highly methylated, including those in the
villous placenta (with 92.5% of methylation level),
despite a lower methylation (68%) of the 30LTR in
this tissue (Fig. 2C). Finally, methylation levels
between HW_4[50LTR] and the upstream MER114
[LTR] part were similar in PBL and placental ﬁbro-
blasts, but in the villous placenta, HW_4[50LTR]
methylation level was much lower (40%) than the
MER114 (70%) (Fig. 2D). Thus, except for
ERVWE1[50LTR] and the upstream MaLR[LTR], there
was no clear correlation between the methylation of
the HERV-W LTRs and their ﬂanking sequence. Reiss
et al.
38 also recently concluded that the hypomethyla-
tion of HERV-E LTRs acting as placenta promoters of
cellular genes, when compared with random LTRs,
cannot be explained by a difference in methylation
of their ﬂanking sequences, irrespective of its
nature—repeated element or not.
The MaLR[LTR] and the ERVWE1[50LTR] elements
have been earlier demonstrated to be co-opted
and to speciﬁcally control ERVWE1 placental
expression.
43,46 Thus, although belonging to distinct
LTR types, their shared unmethylation status in pla-
centa could be linked to their involvement in the
regulation of Syncytin-1 transcription. Likewise, the
heavy methylation of both LTRs in non-placenta cells
supports a repression process outside placenta.
Overall, these results are compatible with ERVWE1
env regulation as a bona ﬁde gene.
45
3.2. 50LTR methylation of HERVs coding for proteins
associated with placenta morphogenesis
3.2.1. Description of the placentally expressed HERV
included in the study ERVFRDE1 Env
(Syncytin-2) and ERV3 Env together with ERVWE1
Env (Syncytin-1) are the three retroviral envelope pro-
teins exhibiting a probable function in placenta devel-
opment.
55 Syncytin-2 and ERV3 Env are, respectively,
encoded by ERVFRDE1, a provirus belonging to the
HERV-FRD family (HERV-FRD_6p24.1; AL136139)
and the provirus ERV3 belonging to the ERV3/
HERV-R family (HERV-R_7q11.2; AC073210). LTR
borders and transcription start sites have already
been published for ERVWE1 and ERV3.
12,43
ERVFRDE1 LTR borders limits were determined using
the RepeatMasker software (www.repeatmasker.org).
ERVFRDE1[50LTR] U3/R boundary, delineating the
202 ERVWE1/Syncytin-1 and Other HERV LTR Methylation [Vol. 16,transcription start site, was located at nt þ492 or nt
þ504 from the [50LTR] 50 end, using four human pla-
cental full-length or 50 end containing mRNAs dis-
playing more than 99% identity with ERVFRDE1
genomic sequence (BC068585, AK123938,
AL543429 and CR626159).
3.2.2. The 50LTR of placentally expressed HERVs
display dissimilar methylation proﬁles in pla-
centa tissues We investigated and com-
pared the 50LTR methylation proﬁles of ERVWE1,
ERVFRDE1 and ERV3 proviruses (schematized in
Fig. 3A), in the same placenta-associated tissues as
done for HERV-W LTRs. It appeared that all three
50LTRs shared a common lack of methylation in
villous placenta but under different modalities.
In addition, their methylation was widely variable in
the non-trophoblastic cells associated with the
placenta.
In villous placenta, ERVWE1[50LTR] had a global
methylation level of 36.7%, and molecules were
bimodally methylated, as mentioned above. An
Figure 3. CpG methylation envelope-coding HERV 50LTRs in placenta-associated tissues. (A) Schematic representation of MaLR[LTR]–
ERVWE1[50LTR] (as in Fig. 2A), ERVFRDE1[50LTR] and ERV3[50LTR] analyzed regions. LTR regions are represented by boxes and CpG
dinucleotides by circles on vertical bars. The U3 region (light gray) constitutes the retroviral promoter, transcription starts at the
U3/R boundary (arrow). Putative transcription factor binding sites proximal to or overlapping CpGs are indicated. Downstream
horizontal bars are provirus internal sequence. (B–E) CpG methylation of (B) MaLR[LTR]–ERVWE1[50LTR] (as in Fig. 1),
(C) ERVFRDE1[50LTR] and (D) ERV3[50LTR]. Methylation was determined by bisulﬁte sequencing PCR in villous trophoblast of term
placenta, related fetal and maternal blood cells and in placental ﬁbroblasts from chorionic villi of a ﬁrst trimester placenta. Each
sample result originates from the same conversion reaction. Each line represents an independent clone as determined by
methylation and/or conversion differences. Methylated CpG are schematized by black circles, unmethylated CpGs by white circles
and CpGs with undetermined methylation state by gray circles. Global methylation percentage values in the U3 regions (highlighted
in gray) as well as in the MaLR[LTR] (in parentheses) are given below the respective area for each sample.
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of 12 clones) was observed (Fig. 3B). In contrast,
methylation of ERVFRDE1[50LTR] was close to zero in
the villous placenta, as only two CpGs were methyl-
ated in the whole sample (Fig. 3C). Finally, methyl-
ation of ERV3[50LTR] reached a level of 23.5% and
was distributed within three principal patterns
(Fig. 3D). Thus, completely unmethylated molecules
were found in high proportion (10 clones out of
17), completely methylated molecules were found
in very low proportion (2 clones) and the remaining
molecules were methylated only at the U3 area
borders (5 clones). Although the methylation distri-
bution of ERVWE1, ERVFRDE1 and ERV3 [50LTRs] was
undoubtedly different, an important amount of
totally unmethylated clones was found for all three
HERV 50LTRs in agreement with their promoter func-
tion and activity in trophoblast.
11
In placenta-associated non-trophoblastic cells, i.e.
PBLs and placental ﬁbroblasts, ERVWE1[50LTR] was
found heavily methylated. ERVFRDE1[50LTR] was also
essentially methylated in placental ﬁbroblasts
(77.9%), albeit CpGs 3, 5 and 8 were regularly
unmethylated. In fetal cord blood cells on the
contrary, the global methylation level of
ERVFRDE1[50LTR] was only 25.3%. This was due to a
quasi-systematic but exclusive methylation on the
CpGs neighboring the TATA box. This accurate methyl-
ation pattern was conserved in maternal blood cells,
although an occasional methylation of the second
CpG site slightly increased the methylation level up
to 30.2%. ERVWE1 high methylation level in non-tro-
phoblastic cells and ERVFRDE1 high methylation in
placental ﬁbroblasts are in agreement with the lack
of expression previously established for ERVWE1 and
ERVFRDE1 env mRNAs in these tissues.
11,14,50 In
spite of this, there is no trivial link between
ERVFRDE1[50LTR] low methylation level in PBLs and
the described weak transcriptional activity of
ERVFDRE1 env (200-fold less than in placenta).
11
One explanation could be that essential transcription
factors needed for ERVFRDE1 transcriptional activity
are missing in PBL. Nonetheless, another explanation
could be related to the precise and accurate methyl-
ation at only the CpGs closed to the TATA box. Such
a local methylation was observed for the RANKL
gene promoter and impaired transcriptional induc-
tion by disturbing the attachment of the TATA
binding protein.
56 Contrary to ERVWE1 and
ERVFRDE1, methylation patterns of ERV3[50LTR] in
maternal blood cells and placental ﬁbroblasts were
highly similar to those found in term trophoblast.
However, the proportion of each pattern and conse-
quently the global methylation level varied depending
on the sample type. Thus, the global methylation of
the ERV3 50LTR U3 region reached 37.5% in maternal
blood (with 6 unmethylated clones out of 16) and
54.6% in placental ﬁbroblasts (with 2 unmethylated
clones out of 11). The variation in their relative pro-
portion could explain the variable levels of ERV3 env
transcription among human tissues in general and
between placenta and PBL
11 in particular. An excep-
tion to this trend of ERV3[50LTR] generic methylation
patterns was the ﬁnding of only one methylated
CpG (equivalent to 1.9% of total methylation) in the
fetal cord PBLs sample. This lack of methylation was
all the more unexpected, since the LTRs of all the
other HERVs analyzed in this study had a conserved
methylation in fetal and adult PBLs. Whether this
lack of methylation correlates with signiﬁcant ERV3
env mRNA and protein levels in fetal PBLs deserves
further investigation.
In conclusion, methylation status of these LTRs is
globally in adequation with their respective promoter
activity and could also be implicated in the modu-
lation of their transcriptional level and consequently
in the biological activity of their protein.
3.2.3. Pregnancy-associated 50LTR methylation
changes in HERV coding for envelope proteins
in cytotrophoblasts ERVWE1, ERVFRDE1
and ERV3 env expression is localized in cytotropho-
blastic cells of the placenta and is temporally regu-
lated during pregnancy, according to a dynamic
speciﬁc to each envelope gene. We further investigate
whether changes in promoter methylation of the
50LTR of these HERVs may contribute to the observed
transcriptional variations. Analyses were carried out in
puriﬁed cytotrophoblasts from one normal ﬁrst trime-
ster placenta (placenta 1.1), trisomic 21 (T-21)
second trimester placentas (placentas 2.1 and 2.2)
and normal term placentas (placentas 3.1, 3.2 and
3.3) (for clarity, results from one sample for each
time of gestation are shown in Fig. 4).
The bimodal methylation pattern previously
observed for the ERVWE1[50LTR] domain
39 and
herein shown to equally affect the associated
MaLR[LTR] TSE in term villous placenta could have
reﬂected an imprinted regulation of ERVWE1, as was
suggested previously.
57 This process is regularly
mediated by the methylation of one of the two
alleles in a parent-of-origin manner and often
related to genes involved in placenta morphogen-
esis.
58 However, the bimodal methylation was not
clearly observed at all stages of pregnancy. Thus, in
the ﬁrst trimester placenta, the MaLR[LTR]–
ERVWE1[50LTR] was not methylated at all (placenta
1.1 Fig. 4B). Among the two second trimester
samples derived from T-21 placentas, placenta 2.1
also showed no methylation at all (not shown),
whereas placenta 2.2 presented one fully methylated
clone out of 12 (Fig. 4B). In contrast, in all the three
204 ERVWE1/Syncytin-1 and Other HERV LTR Methylation [Vol. 16,CT samples derived from term placenta, the bimodal
methylation pattern was clearly observed though
with a signiﬁcant sample-to-sample variation in the
proportion of the two methylation patterns. More
precisely, the number of methylated clones was 1
out of 12 in placenta 3.1 (not illustrated), 5 out of
12 in placenta 3.2 (not illustrated) and 6 out of 14
in placenta 3.3 (Fig. 4B), respectively. In short, the
global amount of methylated CpGs in the
MaLR[LTR]–ERVWE1[50LTR] region varied from 0% in
the ﬁrst trimester placenta to 33.3% at term (as
observed in the term placental villi sample). The
absence of stability in the bimodal repartition of mol-
ecules methylation throughout gestation argues
against the proposed imprinting hypothesis. In con-
trast, the apparent increased frequency of hyper-
methylated sequences from ﬁrst trimester to term is
consistent with the decrease in ERVWE1 env
expression observed between 37 and 40 weeks of
gestation.
59 In addition, the sample-to-sample vari-
ations are compatible with the inter-individual vari-
ation observed for the ERVWE1 expression level.
59
Consequently, ERVWE1 env mRNA down-regulation
in placental dysfunction
59,60 could be related to an
early remethylation of ERVWE1 promoter. The discov-
ery of a single atypical clone exhibiting a methylated
MaLR[LTR] and an unmethylated ERVWE1[50LTR] in
villous placenta (Fig. 3B) may reﬂect a ‘targeted’
remethylation process that would deserve further
investigation.
Contrary to ERVWE1, ERVFRDE1[50LTR] was stably
unmethylated in normal ﬁrst and term cytotropho-
blasts as well as in second trimester T-21 cytotropho-
blasts, as overall methylation in the samples did not
exceed 5.7% (0%, 5.7% and 2.7% in placenta 1.1,
2.2 and 3.3, respectively, see Fig. 4C; and 1.3%, 5.6%
and 3.3% in placenta 2.1, 3.1 and 3.3, respectively,
not illustrated). This stable unmethylation allows a
Figure 4. CpG methylation dynamics of envelope-coding HERV 50LTRs in cytotrophoblasts during pregnancy. (A) Schematic representation
of the MaLR[LTR]–ERVWE1[50LTR], ERVFRDE1[50LTR] and ERV3[50LTR] analyzed regions. (B–D) CpG methylation of (B) MaLR[LTR]–
ERVWE1[50LTR], (C) ERVFRDE1[50LTR] and (D) ERV3[50LTR]. Methylation was determined by bisulﬁte sequencing PCR in
cytotrophoblasts (CT) at different times of gestation. One sample is represented here for each trimester i.e. CT of ﬁrst trimester
placenta from legally induced abortion (placenta 1.1), second trimester placenta from trisomy 21-affected pregnancy (T21,
placenta 2.2) and term placenta from healthy mother (placenta 3.3). Each sample result originates from the same conversion
reaction. Each line represents an independent molecule. Methylated CpGs are schematized by black circles and unmethylated CpGs
by white circles.
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account for transcriptional modulations. Thus,
ERVFRDE1 env mRNA progressive decrease along ges-
tation
61 and down-regulation in T-21 affected pla-
centa
62 might preferentially be linked to a
modulation of the transcription factor pool rather
than to alteration of the LTR methylation.
ERV3 [50LTR] methylation levels [investigated in one
representative CT sample for each stage of pregnancy,
i.e. placentas 1.1, 2.2 and 3.3 (Fig. 4D)] were some-
what same during all gestation. Hence, in the U3
region, 29.2% of the CpGs were methylated in the
ﬁrst trimester, 18.2% in the second trimester and
25.4% at term. Still, as in ERVWE1, ERV3[50LTR]
methylation pattern did change. However, these
changes were not progressive but more drastically
linked to the gestation stage, and differences were
more particularly obvious between the ﬁrst and the
second trimester. Indeed and interestingly,
ERV3[50LTR] methylation proﬁle in the ﬁrst trimester
was very similar to the one observed for
ERVFRDE1[50LTR] in blood, i.e. precisely and systemati-
cally associated with the TATA box. The fact that this
precise promoter methylation has been found for
the conventional RANKL gene,
56 and herein for two
unrelated HERVs (ERV3 and ERVFRDE1, see Fig. 3C),
might indicate an important regulation mechanism
and would have to be studied further. ERV3 expression
in placenta along gestation has been described spar-
sely. However, under the same hypothesis as proposed
above for ERVFRDE1, this methylation pattern could
correlate with the faint or absent ERV3 env expression
in the ﬁrst trimester highly proliferative CTs.
63,64 In
the second trimester CT sample, we could observe
lower methylation of these CpGs leading to an
unmethylated U3 region in 5 of the 11 sequences.
In contrast, a new methylation occurred on the ﬁrst
CpG downstream from the LTR on all clones, which
was never methylated in the ﬁrst trimester. Finally,
three methylation patterns were observed in term
CTs, which were similar to those of the term villous
placenta sample. Thus, over the 15 clones analyzed,
8 were completely unmethylated in the U3 area,
whereas the others were methylated along the
whole U3 region or only on the ﬁrst and last CpGs.
Correlating with ERV3 env highest expression,
63,64
the maximal number of unmethylated ERV3[50LTR]
U3 sequences was found at this stage of pregnancy.
Altogether, these results support the hypothesis
that the transcriptional activity of these domesticated
proviruses is epigenetically controlled and that
methylation might be further involved in the develop-
mentally associated regulation of, at least, ERVWE1
env and ERV3 env transcriptional levels in placenta
and possibly of ERV3 env in PBLs. Whether the epige-
netic picture observed in the second trimester reﬂects
the 15–25 weeks of amenorrhea or the T-21 patho-
logical context deserves further investigations.
3.3. Association between HERV LTRs methylation
and transcriptional activity
To investigate whether a systematic correlation
exists between LTRs methylation status and transcrip-
tional activities, we conducted paralleled transcription
and methylation analyses in various cell lines, namely
BeWo (choriocarcinoma), U937 (monocytes),
85HG66 (astrocytoma) and OVCAR-3 (ovarian carci-
noma). Although the situation appears complex
(Fig. 5), we identiﬁed essentially four situations.
First, there is a strong correlation between tran-
scription and methylation. Thus, ERVWE1 and
ERVFRED1 env transcription in placental BeWo cells
was correlated with their 50LTR fully unmethylated
status. Similarly, faint transcription (below 2 copies/
10 cell) was mostly associated with a high and homo-
geneous methylation of LTRs (e.g. ERVWE1[50LTR] in
U397 and ERVFRDE1[50LTR] in OVCAR-3).
Second, comparison of ERVWE1 LTRs and
HW_12[solo LTR] suggests that the absence of
expression is highly correlated with a huge methyl-
ation for functional LTRs (ERVWE1), in contrast to
the HW_12[solo LTR] which displays a signiﬁcant
amount of unmethylated U3 regions in 85HG66
and OVCAR-3 cells. This LTR, which exhibits extremely
heterogeneous methylation status, is probably not
functional; even if we cannot exclude that the lack
of related transcription could be attributed to tran-
scription factors paucity.
Third, comparison of ERVFRDE1 and HW_4 in
85HG66 suggests different processes impairing the
activity of these functional 50LTRs. ERVFRDE1 lack of
expression is surely due to dedicated transcriptional
activators deﬁcit rather than methylation as several
molecules are unmethylated. In contrast, HW_4 lack
of expression could be due to the systematic methyl-
ation of the CpGs at the 50LTR U3/R boundary.
The fourth situation, concerning ERV3[50LTR], is
more complex. In U937 cells, the env region was
very poorly expressed, although the 50LTR had, so to
say, no methylated CpGs. Yet, this permissive methyl-
ation is compatible with the induction of ERV3 env
upon U937 stimulation with differentiating agents
such as retinoic acid.
65 In contrast, in 85HG66,
BeWo and to a lesser extent in OVCAR-3, we observed
a high expression level of the env region, but mean-
while a strong methylation level of ERV3[50LTR].
Analysis of ERV3 env containing mRNA using the
USCS genome browser (http://genome.ucsc.edu/cgi-
bin/hgTracks, chr7:64088622–64104466) suggests
the existence of an alternative initiation site in
addition to the published initiation site in the
206 ERVWE1/Syncytin-1 and Other HERV LTR Methylation [Vol. 16,Figure 5. LTR promoter methylation and derived transcriptional activity. LTR-derived transcriptional activity in cell lines is represented by
histograms, and the associated methylation proﬁles of the U3 promoter region of the LTRs are represented underneath. Real-time qPCR
values were normalized by the geometric mean of HPRT and 18S housekeeping genes average and are expressed in copy number/1000
cells or 12.5 ng total RNA (numbers on the top of each bar). The associated methylation proﬁles were determined by bisulﬁte
sequencing PCR. Each sample result originates from the same conversion reaction by bisulﬁte. Each line represents an independent
molecule. Methylated CpGs are schematized by black circles and unmethylated CpGs by white circles. Percentage values express the
global methylation level in the U3 promoter region. MaLR[LTR] methylation percentages are shown in parentheses.
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12 The mRNA AK295189, which has
99.8% identity with the genomic sequence, notably
supports this. It encompasses the full-length ERV3
env region, but not the retroviral sequence ahead,
and starts about 7240 bp upstream from the
ERV3[50LTR] transcription start site. It is thus conceiva-
ble that in the cell lines 85HG66, BeWo and possibly
in OVCAR-3, the observed transcription is related to
such an alternate mRNA form. Alternatively although
uncommon, we cannot exclude that the ERV3 promo-
ter contains methylation-dependent transcription
factor binding sites, as recently described for
Epstein–Barr virus.
66
ERVWE1 is the only known HERV with a juxtaposed
enhancer. This TSE is part of a MaLR LTR, and interest-
ingly, all the MaLR CpG sites are located within the
TSE. We were thus interested to know the extent to
which methylation of the TSE could inﬂuence
ERVWE1 transcriptional activity. Progressively
50deleted MaLR[LTR]–ERVWE1[50LTR] reporter con-
structs (simpliﬁed ‘TSE-U3’, ‘U3 full-length’ and ‘U3
minimal’ promoters, see Fig. 6A) were gradually
methylated, transfected in BeWo cell and analyzed
for luciferase activity (Fig. 6B). The TSE-U3 promoter
activity was the maximal among the three promoter
constructs in unmethylated state, but dropped dra-
matically when methylated. Thus, after 30 min of
methylation (incomplete methylation), we observed
a 5.4-fold decrease in comparison with only 3- and
1.8-fold for the U3 full-length and minimal promo-
ters. Still, in this state, the TSE-U3 promoter activity
remained the highest with 18.4% of the maximal
activity, compared with only 10% for the TSE-
deleted construct. Further increase in the methylation
time to complete methylation reduced the activities
to about the same level, i.e. 12.5% for TSE-U3 promo-
ter, 8.5% for the full-length U3 promoter and 7.6% for
the minimal U3 promoter. In line with the observed
conjoint methylation status of the MaLR[LTR] and
ERVWE1[50LTR], these results underline the impor-
tance of the total absence of methylated CpGs on
both LTRs to obtain maximal transcription and, con-
versely the need of a concomitant methylation of
both LTRs for an efﬁcient repression.
4. Conclusions
Our analyses provide evidence that methylation
status of ERVWE1 and other HERV-W LTRs are not
related to a family/phylogenetically related process,
nor are they systematically correlated with the inte-
gration surrounding area. However, they support both
tissue- and locus-speciﬁc methylation processes for
functional LTRs. Still, methylation status seems to
differ in relation to the promoter/enhancer role of
the LTR or its use as polyadenylation signal. In addition,
ourresultssuggestthatmethylationofHERVLTRscould
be involved in the modulation of their activity. Thus,
this could be achieved in several ways, through an
enhancer/promoter epigenetic co-regulation (e.g.
MaLR[LTR] and ERVWE1[50LTR]) or through a variation
Figure 6. Effect of CpG methylation on MaLR[LTR]–ERVWE1[50LTR]
promoter strength. (A). Schematic representation of TSE-U3, U3
full-length and U3 minimal promoter constructs. Numbering
starts from the ﬁrst position in ERVWE1 50LTR. Effective and
putative transcription factor binding sites associated with the
MaLR[LTR] TSE region (Sp-1, c-myb, GCMA, GATA), with the
ERVWE1[50LTR] U3 50-subdomain (GATA, Pit-1a, ERalpha, Sp-1,
Ap-2 and Oct-1), and CAAT and TATA boxes are indicated by
black boxes. CpGs are depicted by circles on vertical bars.
(B). Relative promoter activities in BeWo cells following in vitro
methylation. pGL-LTR ﬁreﬂy luciferase plasmids were
methylated in vitro during 30, 60 and 240 min, with and
without -SAM. On the basis of restriction proﬁles with BstUI
enzyme -SAM controls were, as expected, not methylated, and
methylation level did not evolve anymore after 60 min
indicating a similar methylation at 60 and 240 min. Plasmid
methylated during 30 and 240 min and -SAM controls were
transfected in BeWo b30 choriocarcinoma cells, which contain
all the necessary factors for MaLR[LTR]–ERVWE1[50LTR]
promoter activity. Fireﬂy luciferase activities were normalized
to the activity of the co-transfected pRL-TK Renilla luciferase
plasmids. The mean and standard deviation from at least three
independent experiments are shown and expressed as a
percentage of the maximal activity. Promoter activity of the
vector backbone represents ,0.3% of the larger TSE-U3
construct and ,1.3% of the U3 minimal promoter construct
(not shown).
208 ERVWE1/Syncytin-1 and Other HERV LTR Methylation [Vol. 16,in cell proportion with unmethylated LTR (e.g.
ERVWE1[50LTR]inCTs)orelse,by targetingpreferential
CpG sites such as CpGs closed to the TATA box (e.g.
ERVFRDE1[50LTR] in PBL, ERV3[50LTR] in ﬁrst trimester
CTs). Thus, the selective and temporal unmethylation
of ERVWE1[50LTR] in placenta during the ﬁrst trimester
may allow Syncytin-1-mediated cell differentiation/
fusion.
6 In contrast, increased methylation at term
may limit Syncytin-1 production and consequent cell
fusion or putative anti-apoptotic protection
7 in
accordance with CT limited fusion and higher apopto-
sisrate.Syncytin-1transcriptionalalterationsobserved
in placental pathologies
59,60 could similarly be associ-
ated with a temporally deregulated methylation of
ERVWE1. Likewise, local methylation of the ERV3 pro-
moter during the ﬁrst trimester may limit ERV3 Env
production and consequent inhibition of early CT pro-
liferation.
15 In contrast, hypomethylation of ERV3 pro-
moter in the second trimester or term placenta and in
fetal blood cells may allow ERV3 Env expression and
consequently, contribute to immunosuppression.
13
So, apparently convergent tropism and redundant
functions, such as fusion for Syncytin-1 (ERVWE1)
and Syncytin-2 (ERVFRDE1) or immunosuppression
for Synctin-2 and ERV3-Env, do not strictly match
with similar methylation regulation. Sequence deter-
minants and mechanisms involved in LTR methylation
need to be further investigated to better understand
HERV regulations and deregulations associated with
pathologies.
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